Arrowstreet Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$35.2M Buy
2025
Q2
$7.26M Buy
2023
Q4
Sell
2023
Q3
$1.14M Buy
2022
Q3
Sell
2022
Q2
$861K Buy
2021
Q1
Sell
2020
Q4
$326K Sell
2020
Q3
$5.93M Sell
2020
Q2
$13.9M Buy
2020
Q1
$1.39M Sell
2019
Q4
$27.7M Buy